Rice H E, Brown R L, Gollin G, Caty M G, Gilbert J, Skinner M A, Glick P L, Azizkhan R G
Division of Pediatric Surgery, Campus Box 3815, Duke University Medical Center, Durham, NC 27710, USA.
Arch Surg. 2001 Dec;136(12):1391-5. doi: 10.1001/archsurg.136.12.1391.
For children with perforated appendicitis, the use of a prolonged course of intravenous (i.v.) antibiotics is equivalent to a short course of i.v. antibiotics followed by sequential conversion to oral (PO) antibiotics.
Prospective, randomized, clinical trial.
Multicenter study in tertiary children's hospitals.
Children (aged 5-18 years) with perforated appendicitis found at laparotomy.
Children were randomized after appendectomy either to a 10-day course of a combination of i.v. ampicillin, gentamicin sulfate, and clindamycin (n = 10); or to a short course of a combination of i.v. ampicillin, gentamicin, and clindamycin, followed by conversion to a combination of p.o. amoxicillin and clavulanate potassium plus metronidazole (n = 16).
The primary outcome measure was clinical success, which was rated as complete, partial, or failure. Secondary outcome measures included return of oral intake, duration of fever, return of normal white blood cell count, and patient charges. Treatment equivalence was determined using confidence interval analysis.
We found treatment equivalence between the i.v. and i.v./p.o. groups, with 6 (60%) complete and 4 (40%) partial successes for the 10 patients in the i.v. group and 15 (94%) complete and 1 (6%) partial successes for the 16 patients in the i.v./p.o. group (P< or =.05). There was no difference in return of oral intake, duration of fever, or return of normal white blood cell count between the groups. Conversion to oral therapy results in savings of approximately $1500 per case.
There is treatment equivalence between prolonged i.v. therapy and i.v. therapy followed by conversion to oral antibiotic therapy in children with perforated appendicitis.
对于患有穿孔性阑尾炎的儿童,长期静脉注射抗生素与短期静脉注射抗生素后序贯转换为口服抗生素等效。
前瞻性、随机临床试验。
三级儿童医院的多中心研究。
剖腹手术时发现患有穿孔性阑尾炎的儿童(5至18岁)。
阑尾切除术后,儿童被随机分为两组,一组接受为期10天的静脉注射氨苄西林、硫酸庆大霉素和克林霉素联合治疗(n = 10);另一组先接受短期静脉注射氨苄西林、庆大霉素和克林霉素联合治疗,然后转换为口服阿莫西林和克拉维酸钾联合甲硝唑治疗(n = 16)。
主要观察指标为临床疗效,分为完全缓解、部分缓解或失败。次要观察指标包括口服摄入恢复情况、发热持续时间、白细胞计数恢复正常情况以及患者费用。使用置信区间分析确定治疗等效性。
我们发现静脉注射组和静脉注射/口服组之间治疗等效,静脉注射组的10名患者中有6例(60%)完全缓解和4例(40%)部分缓解,静脉注射/口服组的16名患者中有15例(94%)完全缓解和1例(6%)部分缓解(P≤0.05)。两组在口服摄入恢复情况、发热持续时间或白细胞计数恢复正常情况方面没有差异。转换为口服治疗后,每例患者可节省约1500美元。
对于患有穿孔性阑尾炎的儿童,长期静脉注射治疗与静脉注射治疗后转换为口服抗生素治疗等效。